NASDAQ:LEXX

Lexaria Bioscience Stock News

Healthcare > Biotechnology

Buy LEXX

*Your capital is at risk

$0.595

-0.0517 (-8.00%)

At Close: Jul 13, 2026

Lexaria Bioscience Corp. Discusses $11 Million Public Offering and 2021 Goals with The Stock Day Podcast

10:09am, Thursday, 28'th Jan 2021

Phoenix, Arizona--(Newsfile Corp. - January 28, 2021) - The Stock Day Podcast welcomed Lexaria Bioscience Corp. (NASDAQ: LEXX) (CSE: LXX) ("the Company"), a company with the proprietary drug delivery

Lexaria Bioscience Corp. Announces Closing of $11 Million Public Offering with Full Exercise of Underwriter Option to Purchase Additional Shares and Warrants

06:30am, Friday, 15'th Jan 2021

KELOWNA, BC / ACCESSWIRE / January 15, 2021 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW)(CSE:LXX) (the "Company") today announced the closing of its previously announced underwritten public

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by